Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Early results with the use of heparin-bonded stent graft to rescue failed angioplasty of chronic femoropopliteal occlusive lesions: TASC D lesions have a poor outcome.

Kuhan G, Abisi S, Braithwaite BD, MacSweeney ST, Whitaker SC, Habib SB.

Cardiovasc Intervent Radiol. 2012 Oct;35(5):1023-8. Epub 2012 Jun 14.

PMID:
22696009
2.

Clinical outcomes and implications of failed infrainguinal endovascular stents.

Gur I, Lee W, Akopian G, Rowe VL, Weaver FA, Katz SG.

J Vasc Surg. 2011 Mar;53(3):658-66; discussion 667. doi: 10.1016/j.jvs.2010.09.069. Epub 2011 Jan 22.

3.

Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).

Lammer J, Zeller T, Hausegger KA, Schaefer PJ, Gschwendtner M, Mueller-Huelsbeck S, Rand T, Funovics M, Wolf F, Rastan A, Gschwandtner M, Puchner S, Ristl R, Schoder M.

J Am Coll Cardiol. 2013 Oct 8;62(15):1320-7. doi: 10.1016/j.jacc.2013.05.079. Epub 2013 Jul 10.

4.

Heparin-bonded stent-graft for the treatment of TASC II C and D femoropopliteal lesions: the Viabahn-25 cm trial.

Zeller T, Peeters P, Bosiers M, Lammer J, Brechtel K, Scheinert D, Rastan A, Noory E, Beschorner U.

J Endovasc Ther. 2014 Dec;21(6):765-74. doi: 10.1583/14-4790R.1.

PMID:
25453876
5.

Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.

Tran K, Ullery BW, Kret MR, Lee JT.

Ann Vasc Surg. 2017 Jan;38:90-98. doi: 10.1016/j.avsg.2016.08.006. Epub 2016 Aug 20.

PMID:
27554688
6.

Results with Viabahn-assisted subintimal recanalization for TASC C and TASC D superficial femoral artery occlusive disease.

Schneider JR, Verta MJ, Alonzo MJ, Hahn D, Patel NH, Kim S.

Vasc Endovascular Surg. 2011 Jul;45(5):391-7. doi: 10.1177/1538574411405548. Epub 2011 Jun 12.

PMID:
21669863
7.

Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent.

Nguyen BN, Conrad MF, Guest JM, Hackney L, Patel VI, Kwolek CJ, Cambria RP.

J Vasc Surg. 2011 Oct;54(4):1051-1057.e1. doi: 10.1016/j.jvs.2011.03.283. Epub 2011 Jun 2.

8.

Percutaneous angioplasty and stenting of the superficial femoral artery.

Surowiec SM, Davies MG, Eberly SW, Rhodes JM, Illig KA, Shortell CK, Lee DE, Waldman DL, Green RM.

J Vasc Surg. 2005 Feb;41(2):269-78.

9.

Subintimal angioplasty of chronic total occlusion in iliac arteries: a safe and durable option.

Chen BL, Holt HR, Day JD, Stout CL, Stokes GK, Panneton JM.

J Vasc Surg. 2011 Feb;53(2):367-73. doi: 10.1016/j.jvs.2010.08.073. Epub 2010 Oct 27.

10.

Results of second-time angioplasty and stenting for femoropopliteal occlusive disease and factors affecting outcomes.

Robinson WP 3rd, Nguyen LL, Bafford R, Belkin M.

J Vasc Surg. 2011 Mar;53(3):651-7. doi: 10.1016/j.jvs.2010.09.020. Epub 2010 Dec 3.

11.

Iliac artery stenting combined with open femoral endarterectomy is as effective as open surgical reconstruction for severe iliac and common femoral occlusive disease.

Piazza M, Ricotta JJ 2nd, Bower TC, Kalra M, Duncan AA, Cha S, Gloviczki P.

J Vasc Surg. 2011 Aug;54(2):402-11. doi: 10.1016/j.jvs.2011.01.027. Epub 2011 Apr 30.

12.

Selective stenting in subintimal angioplasty: analysis of primary stent outcomes.

Schmieder GC, Richardson AI, Scott EC, Stokes GK, Meier GH 3rd, Panneton JM.

J Vasc Surg. 2008 Nov;48(5):1175-80; discussion 1180-1. doi: 10.1016/j.jvs.2008.05.080. Epub 2008 Sep 7.

13.

Heparin-bonded, expanded polytetrafluoroethylene-lined stent graft in the treatment of femoropopliteal artery disease: 1-year results of the VIPER (Viabahn Endoprosthesis with Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease) trial.

Saxon RR, Chervu A, Jones PA, Bajwa TK, Gable DR, Soukas PA, Begg RJ, Adams JG, Ansel GM, Schneider DB, Eichler CM, Rush MJ.

J Vasc Interv Radiol. 2013 Feb;24(2):165-73; quiz 174. doi: 10.1016/j.jvir.2012.10.004. Epub 2013 Jan 28.

PMID:
23369553
14.

Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease.

Dosluoglu HH, Cherr GS, Lall P, Harris LM, Dryjski ML.

J Vasc Surg. 2008 Nov;48(5):1166-74. doi: 10.1016/j.jvs.2008.06.006. Epub 2008 Aug 9.

15.

Infrainguinal atherectomy: a retrospective review of a single-center experience.

Biskup NI, Ihnat DM, Leon LR, Gruessner AC, Mills JL.

Ann Vasc Surg. 2008 Nov;22(6):776-82. doi: 10.1016/j.avsg.2008.08.003.

PMID:
18992666
16.

Clinical outcomes of endovascular treatment of TASC-II C and D femoropopliteal lesions with the Viabahn endoprosthesis.

Mohr PJ, Oyama JK, Luu JT, Stinis CT.

Cardiovasc Revasc Med. 2015 Dec;16(8):465-8. doi: 10.1016/j.carrev.2015.09.001. Epub 2015 Sep 10.

PMID:
26483319
17.

Long-term outcomes for systematic primary stent placement in complex iliac artery occlusive disease classified according to Trans-Atlantic Inter-Society Consensus (TASC)-II.

Ichihashi S, Higashiura W, Itoh H, Sakaguchi S, Nishimine K, Kichikawa K.

J Vasc Surg. 2011 Apr;53(4):992-9. doi: 10.1016/j.jvs.2010.10.069. Epub 2011 Jan 7.

18.

Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve-month results from the SALVAGE study.

Laird JR Jr, Yeo KK, Rocha-Singh K, Das T, Joye J, Dippel E, Reddy B, Botti C, Jaff MR.

Catheter Cardiovasc Interv. 2012 Nov 1;80(5):852-9. doi: 10.1002/ccd.23475. Epub 2012 Mar 15.

PMID:
22422738
19.

Iliac artery stenting versus surgical reconstruction for TASC (TransAtlantic Inter-Society Consensus) type B and type C iliac lesions.

Timaran CH, Prault TL, Stevens SL, Freeman MB, Goldman MH.

J Vasc Surg. 2003 Aug;38(2):272-8.

20.

Supplemental Content

Support Center